Bloom SR - Search Results

1

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Borg CM, et al. Among authors: bloom sr. Br J Surg. 2006 Feb;93(2):210-5. doi: 10.1002/bjs.5227. Br J Surg. 2006. PMID: 16392104

2

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. le Roux CW, et al. Among authors: bloom sr. Ann Surg. 2006 Jan;243(1):108-14. doi: 10.1097/01.sla.0000183349.16877.84. Ann Surg. 2006. PMID: 16371744 Free PMC article.

3

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T. le Roux CW, et al. Among authors: bloom sr. Ann Surg. 2007 Nov;246(5):780-5. doi: 10.1097/SLA.0b013e3180caa3e3. Ann Surg. 2007. PMID: 17968169 Clinical Trial.

4

Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels.

Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Borg CM, et al. Among authors: bloom sr. Obes Surg. 2007 Sep;17(9):1193-8. doi: 10.1007/s11695-007-9211-2. Obes Surg. 2007. PMID: 18074494

5

Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.

le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, Goodlad R, Ghatei MA, Patel A, Bloom SR, Aylwin SJ. le Roux CW, et al. Among authors: bloom sr. Ann Surg. 2010 Jul;252(1):50-6. doi: 10.1097/SLA.0b013e3181d3d21f. Ann Surg. 2010. PMID: 20562614

6

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR. le Roux CW, et al. Among authors: bloom sr. Endocrinology. 2006 Jan;147(1):3-8. doi: 10.1210/en.2005-0972. Epub 2005 Sep 15. Endocrinology. 2006. PMID: 16166213

7

Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.

Fenske WK, Bueter M, Miras AD, Ghatei MA, Bloom SR, le Roux CW. Fenske WK, et al. Among authors: bloom sr. Int J Obes (Lond). 2012 Mar;36(3):379-84. doi: 10.1038/ijo.2011.126. Epub 2011 Jun 21. Int J Obes (Lond). 2012. PMID: 21694700

8

Alterations of sucrose preference after Roux-en-Y gastric bypass.

Bueter M, Miras AD, Chichger H, Fenske W, Ghatei MA, Bloom SR, Unwin RJ, Lutz TA, Spector AC, le Roux CW. Bueter M, et al. Among authors: bloom sr. Physiol Behav. 2011 Oct 24;104(5):709-21. doi: 10.1016/j.physbeh.2011.07.025. Epub 2011 Jul 30. Physiol Behav. 2011. PMID: 21827777 Free article. Clinical Trial.

9

A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.

Brynes AE, Mark Edwards C, Ghatei MA, Dornhorst A, Morgan LM, Bloom SR, Frost GS. Brynes AE, et al. Among authors: bloom sr. Br J Nutr. 2003 Feb;89(2):207-18. doi: 10.1079/BJN2002769. Br J Nutr. 2003. PMID: 12575905 Free article. Clinical Trial.

10

Inhibition of food intake in obese subjects by peptide YY3-36.

Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Batterham RL, et al. Among authors: bloom sr. N Engl J Med. 2003 Sep 4;349(10):941-8. doi: 10.1056/NEJMoa030204. N Engl J Med. 2003. PMID: 12954742 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,725 results

Search Page